Table 1 General characteristics of the study population

Age (years), mean(SD)

83.6 (7.2)

Sex (Female), n (%)

1413 (77%)

Hospitalization length, median (IQR)

9 (7–13)

MNA, n(%)

 At risk

888 (53%)

 Malnourished

202 (12%)

CCI, median(IQR)

5 (4–7)

Diabetes Mellitus, n(%)

392 (22%)

CKD (Moderate-severe), n(%)

231 (13%)

CHF, n(%)

204 (12%)

Myocardial Infarction, n(%)

305 (17%)

COPD, n(%)

157 (9%)

Peripheral vascular disease, n(%)

252 (14%)

Dementia, n(%)

537 (30%)

ADL, median(IQR)

5 (3–6)

ADL disability, n(%)^a

754 (43%)

Setting at discharge, n(%)

 Home

532 (35%)

 Rehabilitation

1010 (65%)

Delirium in 72h after surgery, n(%)

538 (29%)

N drugs at admission, median(IQR)

4 (2–6)

Polypharmacy >5 at admission, n(%)

587 (33%)

Admission

Discharge

Psychoactive drugs, n(%)

 0

1190(64%)

1160 (63%)

 1

474 (26%)

498 (27%)

 2

129 (7%)

145 (8%)

 ≥3

61 (3%)

51 (3%)

Antidepressants

316 (17%)

404 (21.8%)

Anxiolytics

300 (16.2%)

220 (11.9%)

Antipsychotics

198 (10.7%)

204 (11%)

Gabapentinoids

24 (1.3%)

13 (0.7%)

Antiepileptics

12 (0.6%)

15 (0.9%)